Lisa Blackwell
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: November 25, 2017
Interpretation of the evidence for the efficacy and safety of statin therapy.
Journal: Lancet (London, England)
Published: May 13, 2016
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.
Journal: The lancet. Diabetes & endocrinology
Published: May 11, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.
Journal: The Lancet. Neurology
Published: February 19, 2016
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
Journal: Lancet (London, England)
Published: January 13, 2015
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.
Journal: Lancet (London, England)
Published: August 10, 2014
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
Journal: Lancet (London, England)
Published: August 01, 2014
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: March 15, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026